The journal of mental health policy and economics
-
J Ment Health Policy Econ · Jun 2014
Randomized Controlled TrialCost-effectiveness of a randomized trial to treat depression among Latinos.
Rising mental health costs have brought with them the pressing need to identify cost-effective treatments. Identifying cost-effective treatments for depression among Latinos is particularly relevant given substantial disparities in access to depression treatment for Latinos compared to non-Latino whites. ⋯ The finding that phone-based intervention is able to improve the depressive symptoms of patients just as effectively as face-to-face by spending less is crucial for policy makers and health institutions looking to adopt cost-effective depression treatments.
-
J Ment Health Policy Econ · Dec 2009
Randomized Controlled TrialCost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Major depression is a prevalent mental disorder with a high risk of relapses and recurrences, which are associated with considerable burden for patients and high costs for society. Despite these negative consequences, only few studies have focused on interventions aimed at the prevention of recurrences in primary care patients with depression. ⋯ The relatively positive economic results for CBT-enhanced PEP imply that UC enriched with CBT (but without PEP) might be cost-effective in preventing relapses in primary care patients with depression. The actual consequences of CBT for relapse prevention will have to be studied in further detail, both from a clinical and economic point of view.
-
J Ment Health Policy Econ · Mar 2009
Randomized Controlled Trial Multicenter StudyA comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
Economic evaluations of healthcare interventions increasingly measure outcomes using quality-adjusted life years (QALYs). The SF-6D and the EQ-5D are alternative ways of generating utility scores for use in QALY estimations, but it is unclear which is most sensitive to change in psychiatric symptom severity. There are also limited data on the sensitivity of these measures to changes in existing clinical indicators in long-term mental health conditions like schizophrenia. ⋯ Further comparisons of the EQ-5D and SF-6D are required.
-
J Ment Health Policy Econ · Mar 2009
Randomized Controlled TrialCost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Triply diagnosed patients, who live with HIV and diagnosed mental health and substance abuse disorders, account for at least 13% of all HIV patients. This vulnerable population has substantial gaps in their care, attributable in part to the need for treatment for three illnesses from three types of providers. ⋯ Future trials with interventions with lower baseline levels of integration, longer duration and larger sample sizes may show improvement or slow the decline in quality of life. Future researchers should collect comprehensive cost data, because significant decreases in the cost of hospital care did not necessarily lead to significant decreases in the total cost of health services.
-
J Ment Health Policy Econ · Dec 2004
Randomized Controlled Trial Clinical TrialEconomic evaluation of treatments for children with severe behavioural problems.
Disruptive behaviour disorders, including conduct disorder, affect at least 10% of children and are the most common reasons for referral to children's mental health services. The long-term economic impact on society of unresolved conduct disorder can exceed pound sterling 1 million for one individual over their lifetime. ⋯ It would be of interest for further research to continue to follow up the work done in this study with a larger cohort of subjects to further establish the effective components of parenting programmes and their relative costs and benefits both at intervention and over time.